| Variable . | 35 patients (40 stents) . |
|---|---|
| Age | 65.3 ± 10.3 |
| Men (%) | 28 (80) |
| Hypertension (%) | 24 (68) |
| Dyslipidaemia (%) | 26 (74) |
| Cigarette smoking (%) | 17 (49) |
| Diabetes (%) | 19 (54) |
| Renal dysfunction (%) | 7 (20) |
| Prior myocardial infarction (%) | 3 (9) |
| Prior PCI (%) | 8 (23) |
| Prior CABG (%) | 0 (0) |
| Clinical presentation (%) | |
| Stable angina pectoris | 33 (94) |
| Unstable angina pectoris | 2 (6) |
| Statin | 24 (69) |
| ACE-I, ARB | 22 (63) |
| Variable . | 35 patients (40 stents) . |
|---|---|
| Age | 65.3 ± 10.3 |
| Men (%) | 28 (80) |
| Hypertension (%) | 24 (68) |
| Dyslipidaemia (%) | 26 (74) |
| Cigarette smoking (%) | 17 (49) |
| Diabetes (%) | 19 (54) |
| Renal dysfunction (%) | 7 (20) |
| Prior myocardial infarction (%) | 3 (9) |
| Prior PCI (%) | 8 (23) |
| Prior CABG (%) | 0 (0) |
| Clinical presentation (%) | |
| Stable angina pectoris | 33 (94) |
| Unstable angina pectoris | 2 (6) |
| Statin | 24 (69) |
| ACE-I, ARB | 22 (63) |
Values are presented as number of patients (%).
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting, ACE, angiotensin-converting enzyme, ARB, angiotensin II receptor blocker.
| Variable . | 35 patients (40 stents) . |
|---|---|
| Age | 65.3 ± 10.3 |
| Men (%) | 28 (80) |
| Hypertension (%) | 24 (68) |
| Dyslipidaemia (%) | 26 (74) |
| Cigarette smoking (%) | 17 (49) |
| Diabetes (%) | 19 (54) |
| Renal dysfunction (%) | 7 (20) |
| Prior myocardial infarction (%) | 3 (9) |
| Prior PCI (%) | 8 (23) |
| Prior CABG (%) | 0 (0) |
| Clinical presentation (%) | |
| Stable angina pectoris | 33 (94) |
| Unstable angina pectoris | 2 (6) |
| Statin | 24 (69) |
| ACE-I, ARB | 22 (63) |
| Variable . | 35 patients (40 stents) . |
|---|---|
| Age | 65.3 ± 10.3 |
| Men (%) | 28 (80) |
| Hypertension (%) | 24 (68) |
| Dyslipidaemia (%) | 26 (74) |
| Cigarette smoking (%) | 17 (49) |
| Diabetes (%) | 19 (54) |
| Renal dysfunction (%) | 7 (20) |
| Prior myocardial infarction (%) | 3 (9) |
| Prior PCI (%) | 8 (23) |
| Prior CABG (%) | 0 (0) |
| Clinical presentation (%) | |
| Stable angina pectoris | 33 (94) |
| Unstable angina pectoris | 2 (6) |
| Statin | 24 (69) |
| ACE-I, ARB | 22 (63) |
Values are presented as number of patients (%).
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting, ACE, angiotensin-converting enzyme, ARB, angiotensin II receptor blocker.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
